Study of CLL, SLL, and related blood conditions in Italy
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older at the time of diagnosis
- Your diagnosis is CLL, SLL, or CLL-like monoclonal B-cell lymphocytosis (MBL)
- If this is a past group: your diagnosis was from Jan 1, 2010 to Aug 31, 2021
- If this is a newer group: your diagnosis was from Sep 1, 2021 to Sep 1, 2025
- You can provide written informed consent if the study asks for it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This Phase 3 trial studies an early treatment approach for people with high-risk CLL or SLL who have not yet needed standard therapy. It aims to see if treating earlier can improve outcomes while keeping side effects manageable.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This observational study looks at the order of treatments given to people with chronic lymphocytic leukemia (CLL) who took part in certain first-line studies run by the German CLL Study Group. It aims to learn how different treatment sequences affect overall survival over time.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
This registry collects information over time from people with CLL to better understand the disease and its treatment. It does not test any new drugs or procedures.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.